Immunocore Holdings Plc (IMCR)
35.36
-0.77
(-2.13%)
USD |
NASDAQ |
Sep 08, 16:00
35.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunocore Holdings Market Cap : 1.820B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.820B |
| September 04, 2026 | 1.860B |
| September 03, 2026 | 1.934B |
| September 02, 2026 | 1.924B |
| September 01, 2026 | 1.898B |
| August 31, 2026 | 1.870B |
| August 28, 2026 | 1.885B |
| August 27, 2026 | 1.892B |
| August 26, 2026 | 1.911B |
| August 25, 2026 | 1.925B |
| August 24, 2026 | 1.885B |
| August 21, 2026 | 1.899B |
| August 20, 2026 | 1.868B |
| August 19, 2026 | 1.898B |
| August 18, 2026 | 1.854B |
| August 17, 2026 | 1.804B |
| August 14, 2026 | 1.761B |
| August 13, 2026 | 1.761B |
| August 12, 2026 | 1.788B |
| August 11, 2026 | 1.760B |
| August 10, 2026 | 1.749B |
| August 07, 2026 | 1.750B |
| August 06, 2026 | 1.776B |
| August 05, 2026 | 1.714B |
| August 04, 2026 | 1.690B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.648B |
| July 31, 2026 | 1.719B |
| July 30, 2026 | 1.722B |
| July 29, 2026 | 1.699B |
| July 28, 2026 | 1.703B |
| July 27, 2026 | 1.717B |
| July 24, 2026 | 1.779B |
| July 23, 2026 | 1.805B |
| July 22, 2026 | 1.807B |
| July 21, 2026 | 1.753B |
| July 20, 2026 | 1.731B |
| July 17, 2026 | 1.777B |
| July 16, 2026 | 1.752B |
| July 15, 2026 | 1.763B |
| July 14, 2026 | 1.701B |
| July 13, 2026 | 1.652B |
| July 10, 2026 | 1.624B |
| July 09, 2026 | 1.682B |
| July 08, 2026 | 1.717B |
| July 07, 2026 | 1.698B |
| July 06, 2026 | 1.624B |
| July 02, 2026 | 1.652B |
| July 01, 2026 | 1.609B |
| June 30, 2026 | 1.614B |
| June 29, 2026 | 1.546B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Silence Therapeutics Plc | 566.96M |
| Biodexa Pharmaceuticals Plc | 0.3752M |
| NuCana Plc | 6.033M |
| Mereo BioPharma Group Plc | 40.64M |
| Compass Pathways Plc | 1.906B |
Market Cap Related Metrics
| PS Ratio | 4.210 |
| Price to Book Value | 4.361 |
| Price | 35.36 |
| Earnings Yield | -1.05% |